TCG Crossover Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839948

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 54 positions · Total reported value $4.16B · Top-10 concentration 57.4% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 45.9% · 12 new · 9 cut · 7 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +20.4% · vs SPY +5.6% · Prev Value $3.50B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, TCG Crossover Management, LLC disclosed 54 equity positions with a combined reported value of $4.16B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 57.4% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were ABVX ($800.60M), TNGX ($283.88M), CGON ($260.77M). By sector, the heaviest allocations are Health Care 99.3%, Financials 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+4.2pp) and away from Other (-4.4pp).

Versus the prior quarter, TCG Crossover Management, LLC opened 12 new positions, trimmed 9 and fully exited 7, a turnover rate of 45.9% of positions. The portfolio's overlap with the prior quarter was 69% of names.

The largest new positions opened in Q2 2026 were ZLAB ($116.61M), AURA ($67.69M), TRAX ($58.25M).

Of the 7 positions fully exited versus the prior quarter, the largest were CNTA ($170.26M), FULC ($40.27M), LQDA ($15.21M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ZLAB Zai Lab Ltd · $116.61M
  • AURA AURA BIOSCIENCES INC · $67.69M
  • TRAX FIRST TRACKS BIOTHERAPEUTICS ORD SHS · $58.25M
  • EDIT EDITAS MEDICINE INC · $36.00M
  • PHVS PHARVARIS N V · $34.86M
  • IFRX INFLARX NV · $32.48M
  • ALT ALTIMMUNE INC · $30.40M
  • AKTS AKTIS ONCOLOGY INC · $22.45M

Fully Exited (vs previous quarter)

  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $170.26M
  • FULC FULCRUM THERAPEUTICS INC · prev qtr: $40.27M
  • LQDA LIQUIDIA CORPORATION · prev qtr: $15.21M
  • URGN UROGEN PHARMA LTD COM · prev qtr: $7.29M
  • GPCR STRUCTURE THERAPEUTICS INC · prev qtr: $6.77M
  • UPB UPSTREAM BIO INC · prev qtr: $1.63M
  • VTGN VISTAGEN THERAPEUTICS INC · prev qtr: $1.53M

Insider Transactions (Form 4)

Latest TCG Crossover Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TCG Crossover Management, LLC, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 54 positions worth $4.16B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-120001 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $5.06B as of 2026-05-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds
  • Website: tcgcrossover.com

Portfolio Structure

  • 54 positions · $4.16B reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: ABVX (ABIVAX SA) at 19.2%
  • Average position size: $77.05M

Sector Tilt

  • Health Care 99.3%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 12 new, 2 added, 9 reduced, 7 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 99.3%
Financials 0.2%
Other 0.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.01M $800.60M 19.24%
19.24%
Reduce
2 9.08M $283.88M 6.82%
6.82%
Reduce
3 3.67M $260.77M 6.27%
6.27%
Hold
4 4.85M $187.87M 4.51%
4.51%
Reduce
5 4.46M $171.77M 4.13%
4.13%
Hold
6 1.90M $168.73M 4.06%
4.06%
Hold
7 1.68M $163.44M 3.93%
3.93%
Hold
8 1.06M $124.33M 2.99%
2.99%
Hold
9 6.14M $116.61M 2.80%
2.80%
New
10 6.24M $112.14M 2.69%
2.69%
Hold
11 4.62M $111.86M 2.69%
2.69%
Hold
12 11.02M $110.21M 2.65%
2.65%
Hold
13 5.67M $104.44M 2.51%
2.51%
Hold
14 3.25M $103.77M 2.49%
2.49%
Hold
15 4.62M $102.50M 2.46%
2.46%
Hold
16 1.34M $98.14M 2.36%
2.36%
Hold
17 4.27M $79.95M 1.92%
1.92%
Hold
18 12.36M $76.15M 1.83%
1.83%
Hold
19 9.53M $67.69M 1.63%
1.63%
New
20 340.90K $63.84M 1.53%
1.53%
Reduce
21 2.90M $58.25M 1.40%
1.40%
New
22 1.45M $56.32M 1.35%
1.35%
Hold
23 3.02M $55.76M 1.34%
1.34%
Add
24 1.45M $46.97M 1.13%
1.13%
Reduce
25 17.75M $43.40M 1.04%
1.04%
Hold
26 1.20M $41.42M 1.00%
1.00%
Hold
27 2.45M $39.48M 0.95%
0.95%
Hold
28 1.47M $38.23M 0.92%
0.92%
Hold
29 11.11M $36.00M 0.86%
0.86%
New
30 650.00K $35.88M 0.86%
0.86%
Hold
31 1.01M $34.86M 0.84%
0.84%
New
32 3.03M $33.31M 0.80%
0.80%
Hold
33 14.50M $32.48M 0.78%
0.78%
New
34 10.00M $30.40M 0.73%
0.73%
New
35 1.79M $27.49M 0.66%
0.66%
Hold
36 7.92M $26.99M 0.65%
0.65%
Hold
37 2.05M $26.65M 0.64%
0.64%
Hold
38 1.78M $26.49M 0.64%
0.64%
Reduce
39 696.56K $22.45M 0.54%
0.54%
New
40 10.00M $20.10M 0.48%
0.48%
Hold
41 920.00K $19.55M 0.47%
0.47%
New
42 203.33K $18.83M 0.45%
0.45%
Add
43 1.65M $16.18M 0.39%
0.39%
Hold
44 11.39M $12.19M 0.29%
0.29%
Hold
45 5.66M $11.71M 0.28%
0.28%
Reduce
46 1.06M $7.80M 0.19%
0.19%
Reduce
47 406.79K $7.41M 0.18%
0.18%
Hold
48 707.10K $5.88M 0.14%
0.14%
Reduce
49 416.30K $5.49M 0.13%
0.13%
Hold
50 500.00K $5.35M 0.13%
0.13%
New

FAQ

What did TCG Crossover Management, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, TCG Crossover Management, LLC reported 54 equity positions worth $4.16B in aggregate; its largest disclosed positions were ABVX ($800.60M), TNGX ($283.88M), CGON ($260.77M).

How large is TCG Crossover Management, LLC's portfolio?

TCG Crossover Management, LLC reported $4.16B of long equity holdings across 54 positions as of 2026-Q2. Top-10 holdings account for 57.4% of reported value.

What is TCG Crossover Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tcg-crossover-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →